CDK2 is associated mainly with the regulatory subunits including either cyclin A or E with overexpression in human cancer as in ovarian, breast, endometrial, lung and thyroid carcinomas, osteosarcoma, and melanoma [7]. The gene discussed is CDK2; the disease is cancer.